MDWD$13.304.04%-0.56
Mediwound Ltd (MDWD)
Date: 2026-10-30 16:00O: 13.94H: 13.94L: 13.24C: 13.30Vol: 110.1k
Mediwound Ltd stock is traded at $13.30, with a volume of 110,075. It is down -4.04% in the last 24 hours and down -3.41% over the past month. MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
Previous Close:
$13.86
Open:
$13.94
24h Volume:
110,075
Relative Volume:
0.82
Market Cap:
$171.71M
Revenue:
$14.48M
Net Income/Loss:
-$26.11M
P/E Ratio:
-
EPS:
-$2.26
Net Cash Flow:
-$23.86M
1W Performance:
+10.83%
1M Performance:
-3.41%
6M Performance:
-19.39%
1Y Performance:
-28.30%
1-Day Range:
$13.24$13.94
1-Week Range:
$11.80$13.99
52-Week Range:
$11.80$19.70
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDWD Mediwound Ltd | $13.30 | $171.71M | $14.48M | -$26.11M | -$23.86M | -$2.26 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
Mediwound Ltd Stock (MDWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mediwound Ltd Stock (MDWD) Insider Trading
- Rubinstein SamuelSep 01 '26Director
- Transaction
- Sale
- Cost
- $12.72
- #Shares
- 525
- Value ($)
- 6,678
- #Shares Total
- 0
- Hess ShmuelAug 27 '26COO & Chief Commercial Officer
- Transaction
- Sale
- Cost
- $12.92
- #Shares
- 3,958
- Value ($)
- 51,149
- #Shares Total
- 0
- Shmulik HessAug 27 '26Officer
- Transaction
- Proposed Sale
- Cost
- $12.70
- #Shares
- 3,958
- Value ($)
- 50,267
- #Shares Total
- 0
- Hess ShmuelAug 26 '26COO & Chief Commercial Officer
- Transaction
- Sale
- Cost
- $13.00
- #Shares
- 1,865
- Value ($)
- 24,245
- #Shares Total
- 0
- SHAMIR NACHUMJun 03 '26Director
- Transaction
- Buy
- Cost
- $14.00
- #Shares
- 6,000
- Value ($)
- 83,996
- #Shares Total
- 55,815
- Fox David MortonJun 01 '26Director
- Transaction
- Buy
- Cost
- $14.11
- #Shares
- 3,537
- Value ($)
- 49,901
- #Shares Total
- 22,283
- Rubinstein SamuelMay 29 '26Director
- Transaction
- Buy
- Cost
- $14.33
- #Shares
- 150
- Value ($)
- 2,150
- #Shares Total
- 2,993
- Hess ShmuelDec 02 '25Officer
- Transaction
- Proposed Sale
- Cost
- $17.21
- #Shares
- 3,693
- Value ($)
- 63,557
- #Shares Total
- 0
